SlideShare a Scribd company logo
Other Psychotic Disorders
University of Massachusetts, Amherst
Nursing 690
Donna Petko, MSN, RN, APN, FNP-BC
March 30, 2015
Objective
• prevalence
• diagnostic criteria
• development
• functional
consequences
• cultural issues
• measurements
• diagnostic features
• specifiers
• severity levels
• differential diagnoses
• ICD-10 coding
To increase understanding of Other Psychotic Disorders
listed in the DSM-5 (APA, 2013):
Other Psychotic Disorders
Other Psychotic Disorders
Consist of the following (APA, 2013):
• Brief Psychotic Disorder
• Substance/Medication-Induced Psychotic Disorder
• Psychotic Disorder d/t Another Medical Condition
Brief Psychotic Disorder
Prevalence (APA, 2013):
• may account for 9% of cases of first-onset psychosis (US)
• more common in developing countries
• more common in females than males: 2 to 1
Brief Psychotic Disorder cont.
Diagnostic Criteria (APA, 2013):
• Presence of 1 or more of the following:
• Delusions
• Hallucinations
• Disorganized speech
• Grossly disorganized or catatonic behaviors
• Duration ≥1 day to < 1 month
• Not better explained by:
• Major depressive, bipolar disorder with psychotic features
• Another psychotic disorder (schizophrenia or catatonia)
• Not attributable to substance use, another medical condition
Brief Psychotic Disorder cont.
Development and course (APA, 2013):
• May appear in adolescence/early adulthood
• Onset can occur throughout lifespan
• Average age of onset mid 30s
• Diagnosis requires full remission of all symptoms and
eventual return to premorbid level of functioning within
1 month of onset
Brief Psychotic Disorder cont.
Functional Consequences (APA, 2013):
• Despite high rates of relapse, outcome is excellent in
social functioning and symptomatology, for most
individuals
Cultural Issues (APA, 2013):
• Cultural and religious backgrounds must be considered
• E.g., some individuals report hearing voices in religious
ceremonies but these do not persist and are not perceived as
abnormal by the individual’s community
Brief Psychotic Disorder cont.
Measurements:
• Clinician-Rated Dimensions of Psychosis Symptom
Severity (APA, 2013)
• 5-point scale
• Covers 8 domains:
• delusions, hallucinations, disorganized speech, abnormal
psychomotor behavior, negative symptoms, impaired cognition,
depression, and mania
• Useful in treatment planning, prognostic decision-making, and
research on pathophysiological mechanisms
• Use at regular intervals; the higher the score, the worse the
functioning
Brief Psychotic Disorder cont.
Diagnostic Features (APA, 2013):
• Sudden onset of at least one positive symptom:
delusions, hallucinations, disorganized speech, or grossly
abnormal psychomotor behavior, including catatonia
• ≥ 1 day to < 1 month
Specifiers:
• with marked stressors
• without marked stressors
• with postpartum onset
• with catatonia
Brief Psychotic Disorder cont.
Severity Levels (APA, 2013):
• Severity is rated by quantitative assessment:
• Clinician-Rated Dimensions of Psychosis Symptom Severity
Differential Diagnoses (APA, 2013):
• Other medical conditions
• Substance-related disorders
• Depressive/bipolar disorders
• Other psychotic disorders
• Malingering/factitious disorders
• Personality disorders
Brief Psychotic Disorder cont.
ICD-10 Coding (APA, 2013):
• 298.8 (F23)
Substance/Medication-Induced
Psychotic Disorder
Prevalence (APA, 2013):
• Unknown in general population
• Between 7-25% of individuals presenting with first
episode in various settings are reported to have SMIPD
Substance/Medication-Induced
Psychotic Disorder cont.
Diagnostic Criteria (APA, 2013):
• Presence of 1 or both of the following:
• Delusions
• Hallucinations
• Evidence from Hx, PE, or labs of both 1 & 2:
• Symptoms in criterion A developed during/soon after
substance/medication intoxication, exposure or withdrawal
• Involved substance/medication capable of producing symptoms
in criterion A
Substance/Medication-Induced
Psychotic Disorder cont.
Diagnostic Criteria cont. (APA, 2013):
The disturbance:
• not better explained by other psychotic disorder that is
not substance/medication-induced
• does not occur exclusively during the course of a
delirium
• causes clinically significant distress/impairment in social,
occupational, or other areas of functioning
Substance/Medication-Induced
Psychotic Disorder cont.
Development and course (APA, 2013):
• Onset may vary based on substance
• E.g., smoking a high dose of cocaine may induce psychosis within
minutes
• Substance/medication-induced psychotic disorder may
persist even when offending agent is removed
• E.g., amphetamines may induce psychotic states lasting weeks or
longer
• Polypharmacy may cause psychosis
Substance/Medication-Induced
Psychotic Disorder cont.
Functional Consequences (APA, 2013):
• Typically severely disabling and seen more in ER
• Disability is typically self-limited and resolves when
offending agent is removed
Cultural Issues (ISMP, 2003):
• Some cultures/races respond differently to medications
based on genetic differences
• Practices such as fasting may alter medication levels
Substance/Medication-Induced
Psychotic Disorder cont.
Measurements:
• Clinician-Rated Dimensions of Psychosis Symptom
Severity (APA, 2013)
• 5-point scale
• 8 domains:
• delusions, hallucinations, disorganized speech, abnormal
psychomotor behavior, negative symptoms, impaired cognition,
depression, and mania
• Useful in treatment planning, prognostic decision-making, and
research on pathophysiological mechanisms
• Use at regular intervals; the higher the score, the worse the
functioning
Substance/Medication-Induced
Psychotic Disorder cont.
Diagnostic Features (APA, 2013):
• Prominent delusions/hallucinations (Criterion A)
• d/t physiological effects of substance/medication
• must be evidence in Hx, PE, or labs of both:
• symptoms in criterion A developed during or soon after use
• involved substance/medication is capable of producing symptoms in
criterion A
• Not better explained by a psychotic disorder that is not
substance/medication-induced
• Does not occur exclusively during course of a delirium
• Causes clinically significant distress/impairment
Substance/Medication-Induced
Psychotic Disorder cont.
Specifiers (APA, 2013):
• with onset during intoxication
• with onset during withdrawal
Severity Levels (APA, 2013):
• Severity is rated by quantitative assessment:
• Clinician-Rated Dimensions of Psychosis Symptom Severity
Differential Diagnoses (APA, 2013):
• Substance intoxication or substance withdrawal
• Primary psychotic disorder
• Psychotic disorder due to another medical condition
Substance/Medication-Induced
Psychotic Disorder cont.
ICD-10 (APA, 2013, p. 111):
Psychotic Disorder d/t Another
Medical Condition
Prevalence (APA, 2013):
• Estimated lifetime prevalence 0.21-0.54%
• Ages 65+ have > prevalence 0.74%
• More common in untreated endocrine, metabolic,
autoimmune disorders; temporal lobe epilepsy
• Among older individuals, may be higher in females, but
unclear
Psychotic Disorder d/t Another
Medical Condition cont.
Diagnostic Criteria (APA, 2013:
• Prominent hallucinations or delusions
• Evidence from Hx, PE, or labs indicating direct
pathophysiological consequence of another medical
condition
• The disturbance:
• not better explained by another mental disorder
• does not occur exclusively during course of delirium
• causes clinically significant distress/impairment in social,
occupational, or other areas of functioning
Psychotic Disorder d/t Another
Medical Condition cont.
Development and course (APA, 2013):
• May be a single transient state or recurrent
• Treatment of underlying medical condition usually
rectifies, but not always:
• E.g., psychotic symptoms may persist after brain injury
• Condition may be long term in chronic conditions like MS
• Older adults have higher prevalence of the disorder
• d/t increasing medical burden, advanced age, cumulative effects
of age-related processes
• Younger age groups more affected by epilepsy, head
trauma, autoimmune, and neoplastic events
Psychotic Disorder d/t Another
Medical Condition cont.
Functional Consequences (APA, 2013):
• Typically severe due to another medical condition
• Varies considerably by the type of condition
• Likely to improve with successful resolution of condition
Cultural Issues (ISMP, 2003):
• Some cultures/races respond differently to medications
based on genetic differences
• Practices such as fasting may alter medication levels
• Individuals may not take medications to treat medical
conditions d/t cultural norms/expectations
Psychotic Disorder d/t Another
Medical Condition cont.
Measurements:
• Clinician-Rated Dimensions of Psychosis Symptom
Severity (APA, 2013)
• 5-point scale
• Covers 8 domains:
• delusions, hallucinations, disorganized speech, abnormal
psychomotor behavior, negative symptoms, impaired cognition,
depression, and mania
• Useful in treatment planning, prognostic decision-making, and
research on pathophysiological mechanisms
• Use at regular intervals; the higher the score, the worse the
functioning
Psychotic Disorder d/t Another
Medical Condition cont.
Diagnostic Features (APA, 2013):
• Prominent delusions/hallucinations
• Evidence from Hx, PE, labs that disturbance is result of
pathophysiological consequence of another medical
condition
• Not better explained by another mental disorder
• Doe not occur exclusively during course of delirium
• Causes clinically significant stress or impairment in social,
occupational, or other areas of functioning
Psychotic Disorder d/t Another
Medical Condition cont.
Specifiers (APA, 2013):
• Based on predominant symptom:
• With delusions
• With hallucinations
Severity Levels (APA, 2013):
• Severity is rated by quantitative assessment:
• Clinician-Rated Dimensions of Psychosis Symptom Severity
Differential Diagnoses (APA, 2013):
• Delirium
• Substance/medication-induced psychotic disorder
• Psychotic disorder
Psychotic Disorder d/t Another
Medical Condition cont.
ICD-10 (APA, 2013):
• Code based on predominant symptom:
• 293.81 (F06.2) with delusions
• 293.82 (F06.0) with hallucinations
• Coding note:
• Include the name of the other medical condition in the name of
the mental disorder; the other medical condition should be
coded and listed separately immediately before the psychotic
disorder
Test Your Knowledge
Case Study
A 50-year-old man, nonalcoholic, with uncontrolled diabetes mellitus
and hypertension was admitted to the hospital with history of high-
grade fever and cough with scanty expectoration, of 2 days’ duration;
and burning micturition and ulcer over left foot. Clinically the patient
was febrile and diagnosed to have community-acquired left lower lobe
pneumonia with urinary tract infection and cellulites of left foot.
Investigations revealed Hb was 10.4 g/dl, total leukocyte count was
9,500 cells/mm3 with neutrophilia, E.S.R. was 60 mm at one hour,
random blood sugar was 250 mg/dl, blood urea was 25 mg/dl, serum
creatinine was 1.3 mg/dl with normal creatinine clearance, and serum
electrolytes were within normal limits. Peripheral smear for malarial
parasite was negative. Urine microscopy showed 15-18 pus cells/high
power field. However, urine culture was sterile and urine ketone
bodies were negative. Blood and sputum culture did not grow any
organisms (Moorthy, Raghavendra, & Venkatarathnamma, 2008, para.
3).
Case Study cont.
• Final diagnosis of type 2 diabetes mellitus with hypertension with
community-acquired pneumonia and urinary tract infection and
cellulites of left foot with ulcer was made. In view of multiple
infections, intravenous amoxicillin (1 g) and clavulanic acid (200 mg)
every 8th hour were started and continued for 10 days. His general
condition improved, and repeat chest x-ray showed resolution of
pneumonia with better lung aeration. Cellulitis and urinary tract
infection also showed improvement, and blood sugar and
hypertension were under control. After 10 days, oral levofloxacin
(500 mg/day) was started as a sequential therapy in view of
persisting foot ulcer. On the third day of therapy, he became restless
and speech became irrelevant and incoherent. Later he became
abusive, violent and experienced visual hallucinations of people in
his hospital room. Gradually his confusion worsened and he became
more violent in nature. He slept very little (Moorthy et al., 2008,
para. 3).
What do you think is causing the
psychosis?
Case Study cont.
Psychiatric evaluation was suggestive of acute psychosis. The diagnosis
of acute psychosis cannot be attributed to the clinical diagnosis as the
patient had good improvement following 10 days of intravenous
amoxicillin and clavulanic acid therapy. Other conditions like
hypoglycemia, dyselectrolytemia, diabetic ketoacidosis, and meningitis
were ruled out. Other drugs the patient was receiving were insulin,
enalapril, atorvastatin, which are not known to result in such
psychosis. So the likely possibility of levofloxacin-induced acute
psychosis was considered and levofloxacin was stopped. Within 48 h of
stopping levofloxacin, repeat psychiatric evaluation revealed him to be
alert and oriented with no further hallucinations. His speech was
normal in flow and content, and his concentration and recall were
intact. He did not require any antipsychotic medications (Moorthy et
al., 2008, para. 3).
References
American Psychiatric Association. (2013). Clinician-rated
dimensions of psychosis symptom severity. Retrieved
from http://www.psychiatry.org /File%20Library/
Practice/DSM/DSM-5/ClinicianRatedDimensionsOf
PsychosisSymptomSeverity.pdf
American Psychiatric Association. (2013). Diagnostic and
statistical manual of mental disorders (5th ed.).
Washington D.C.: Author.
Institute for Safe Medical Practices. (2003). Cultural diversity and
medication safety. Retrieved from http://www.ismp.org/
newsletters/acutecare/articles/20030904.asp
References cont.
Moorthy, M. Raghavendra, N, & Venkatarathnamma, P.N. (2008).
Levofloxacin-induced acute psychosis. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745871

More Related Content

What's hot

Management of schizophrenia
Management of schizophreniaManagement of schizophrenia
Management of schizophrenia
Swati Arora
 
Differences between DSM - IV and DSM 5
Differences between DSM - IV and DSM 5Differences between DSM - IV and DSM 5
Differences between DSM - IV and DSM 5
Sathish Rajamani
 
Trauma and stressor related disorders
Trauma and stressor related disordersTrauma and stressor related disorders
Trauma and stressor related disorders
MariaCatanese1
 
Somatization disorder
Somatization disorderSomatization disorder
Somatization disorderNeurologyKota
 
Classification of psychiatric disorders
Classification of psychiatric disordersClassification of psychiatric disorders
Classification of psychiatric disorders
Dr. Amit Chougule
 
Depression psychiatry
Depression psychiatryDepression psychiatry
Depression psychiatry
garvsuthar
 
Trauma and Stress related disorders
Trauma and Stress related disorders Trauma and Stress related disorders
Trauma and Stress related disorders
mamtabisht10
 
Major depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentationMajor depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentation
Dryogeshcsv
 
Posttraumatic stress disorder (ptsd)
Posttraumatic stress disorder (ptsd)Posttraumatic stress disorder (ptsd)
Posttraumatic stress disorder (ptsd)
Nilesh Kucha
 
Dsm 5 - An overview
Dsm 5 - An overviewDsm 5 - An overview
Dsm 5 - An overview
Cijo Alex
 
Classification in psychiatry
Classification in psychiatryClassification in psychiatry
Classification in psychiatry
Enoch R G
 
Conversion disorder
Conversion disorderConversion disorder
Conversion disorderAnam_ Khan
 
Disorders of perception
Disorders of perceptionDisorders of perception
Disorders of perception
Dr. Subhendu Sekhar Dhar
 
Depressive disorder
Depressive disorderDepressive disorder
Depressive disorder
Prof. (Dr.) Rahul Sharma
 
Substance Use Disorders in DSM-V
Substance Use Disorders in DSM-VSubstance Use Disorders in DSM-V
Adjustment disorder
Adjustment disorderAdjustment disorder
Adjustment disorder
Deepti Nambiar
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
Richard Asare
 

What's hot (20)

Management of schizophrenia
Management of schizophreniaManagement of schizophrenia
Management of schizophrenia
 
Differences between DSM - IV and DSM 5
Differences between DSM - IV and DSM 5Differences between DSM - IV and DSM 5
Differences between DSM - IV and DSM 5
 
Trauma and stressor related disorders
Trauma and stressor related disordersTrauma and stressor related disorders
Trauma and stressor related disorders
 
Somatization disorder
Somatization disorderSomatization disorder
Somatization disorder
 
Classification of psychiatric disorders
Classification of psychiatric disordersClassification of psychiatric disorders
Classification of psychiatric disorders
 
Dissociative disorder
Dissociative disorderDissociative disorder
Dissociative disorder
 
Depression psychiatry
Depression psychiatryDepression psychiatry
Depression psychiatry
 
Trauma and Stress related disorders
Trauma and Stress related disorders Trauma and Stress related disorders
Trauma and Stress related disorders
 
Major depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentationMajor depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentation
 
Posttraumatic stress disorder (ptsd)
Posttraumatic stress disorder (ptsd)Posttraumatic stress disorder (ptsd)
Posttraumatic stress disorder (ptsd)
 
Dsm 5 - An overview
Dsm 5 - An overviewDsm 5 - An overview
Dsm 5 - An overview
 
Classification in psychiatry
Classification in psychiatryClassification in psychiatry
Classification in psychiatry
 
Psychosis
PsychosisPsychosis
Psychosis
 
Conversion disorder
Conversion disorderConversion disorder
Conversion disorder
 
Disorders of perception
Disorders of perceptionDisorders of perception
Disorders of perception
 
Depressive disorder
Depressive disorderDepressive disorder
Depressive disorder
 
Substance Use Disorders in DSM-V
Substance Use Disorders in DSM-VSubstance Use Disorders in DSM-V
Substance Use Disorders in DSM-V
 
Adjustment disorder
Adjustment disorderAdjustment disorder
Adjustment disorder
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 

Viewers also liked

10.30.08(a): Schizophrenia and other Psychotic Disorders
10.30.08(a): Schizophrenia and other Psychotic Disorders10.30.08(a): Schizophrenia and other Psychotic Disorders
10.30.08(a): Schizophrenia and other Psychotic Disorders
Open.Michigan
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
Bernd Weishaupt
 
Chapter 6 (revised)
Chapter 6 (revised)Chapter 6 (revised)
Chapter 6 (revised)
Vumile Mj Giovanni
 
Schizophreniform case study
Schizophreniform case studySchizophreniform case study
Schizophreniform case study
Azimah Hassan
 
Psychotic Disorders
Psychotic DisordersPsychotic Disorders
Psychotic Disorders
MD Specialclass
 
Abnormal Psychology - Substance-Related Disorders
Abnormal Psychology - Substance-Related DisordersAbnormal Psychology - Substance-Related Disorders
Abnormal Psychology - Substance-Related Disorders
Savipra Gorospe
 
Substance Related Disorders
Substance Related DisordersSubstance Related Disorders
Substance Related Disordersguestd889da58
 

Viewers also liked (9)

Best Practices in Online Teaching Strategies
Best Practices in Online Teaching StrategiesBest Practices in Online Teaching Strategies
Best Practices in Online Teaching Strategies
 
Psychotic Disorders
Psychotic DisordersPsychotic Disorders
Psychotic Disorders
 
10.30.08(a): Schizophrenia and other Psychotic Disorders
10.30.08(a): Schizophrenia and other Psychotic Disorders10.30.08(a): Schizophrenia and other Psychotic Disorders
10.30.08(a): Schizophrenia and other Psychotic Disorders
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Chapter 6 (revised)
Chapter 6 (revised)Chapter 6 (revised)
Chapter 6 (revised)
 
Schizophreniform case study
Schizophreniform case studySchizophreniform case study
Schizophreniform case study
 
Psychotic Disorders
Psychotic DisordersPsychotic Disorders
Psychotic Disorders
 
Abnormal Psychology - Substance-Related Disorders
Abnormal Psychology - Substance-Related DisordersAbnormal Psychology - Substance-Related Disorders
Abnormal Psychology - Substance-Related Disorders
 
Substance Related Disorders
Substance Related DisordersSubstance Related Disorders
Substance Related Disorders
 

Similar to Other Psychotic Disorders

Schizophrenia-Lecture.ppt
Schizophrenia-Lecture.pptSchizophrenia-Lecture.ppt
Schizophrenia-Lecture.ppt
Balinainejoseph
 
Psychiatry and palliative care medicine
Psychiatry and palliative care medicinePsychiatry and palliative care medicine
Psychiatry and palliative care medicineSaleh Uddin
 
Differential diagnosis
Differential diagnosis Differential diagnosis
Differential diagnosis
Nasar Khan
 
5 Somatic symptom disorder.pptx
5 Somatic symptom disorder.pptx5 Somatic symptom disorder.pptx
5 Somatic symptom disorder.pptx
ashenafigezahegn2
 
Schiz.ppt
Schiz.pptSchiz.ppt
Schiz.ppt
RiwaKfoury1
 
Phsychosomatic disorders
Phsychosomatic disordersPhsychosomatic disorders
Phsychosomatic disorders
DR MUKESH SAH
 
Bipolar Disorders I & II
Bipolar Disorders I & IIBipolar Disorders I & II
somatic symptom disorder.ppt
somatic symptom disorder.pptsomatic symptom disorder.ppt
somatic symptom disorder.ppt
DrMOHITBANSAL2
 
Schizophrenia spectrum & other psychotic disorders.pptx
Schizophrenia spectrum & other psychotic disorders.pptxSchizophrenia spectrum & other psychotic disorders.pptx
Schizophrenia spectrum & other psychotic disorders.pptx
MahnoorHashmi
 
Somatoform disorders
Somatoform disorders Somatoform disorders
Somatoform disorders
FemiOpadotun
 
Seminar on approach to schizophrenia.pptx
Seminar on approach to schizophrenia.pptxSeminar on approach to schizophrenia.pptx
Seminar on approach to schizophrenia.pptx
firaolgebisa
 
OVERVIEW OF SOMATOFORM DISORDERS AND ITS MANAGEMENT.pptx
OVERVIEW OF SOMATOFORM DISORDERS AND ITS MANAGEMENT.pptxOVERVIEW OF SOMATOFORM DISORDERS AND ITS MANAGEMENT.pptx
OVERVIEW OF SOMATOFORM DISORDERS AND ITS MANAGEMENT.pptx
ValentinaEmeruwa
 
adjustment disorders and distress in Palliative care
adjustment disorders and distress in Palliative careadjustment disorders and distress in Palliative care
adjustment disorders and distress in Palliative care
ruparnakhurana
 
basic concepts about schizophrenia spectrum (1).pptx
basic concepts about schizophrenia spectrum (1).pptxbasic concepts about schizophrenia spectrum (1).pptx
basic concepts about schizophrenia spectrum (1).pptx
Natnael21
 
SOMATOFORM AND DISSOCIATIVE DISORDERS
SOMATOFORM AND DISSOCIATIVE DISORDERSSOMATOFORM AND DISSOCIATIVE DISORDERS
SOMATOFORM AND DISSOCIATIVE DISORDERS
ANCYBS
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
GOURIPRIYA L S
 
Unit 6 Psychological disorders and therapy.pptx
Unit 6 Psychological disorders and therapy.pptxUnit 6 Psychological disorders and therapy.pptx
Unit 6 Psychological disorders and therapy.pptx
ameyjoshi69
 
Dr chakor
Dr chakorDr chakor
Dr chakor
Poojakumari350
 
the-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdfthe-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdf
PiyushSharma12895
 
the-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdfthe-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdf
PiyushSharma358470
 

Similar to Other Psychotic Disorders (20)

Schizophrenia-Lecture.ppt
Schizophrenia-Lecture.pptSchizophrenia-Lecture.ppt
Schizophrenia-Lecture.ppt
 
Psychiatry and palliative care medicine
Psychiatry and palliative care medicinePsychiatry and palliative care medicine
Psychiatry and palliative care medicine
 
Differential diagnosis
Differential diagnosis Differential diagnosis
Differential diagnosis
 
5 Somatic symptom disorder.pptx
5 Somatic symptom disorder.pptx5 Somatic symptom disorder.pptx
5 Somatic symptom disorder.pptx
 
Schiz.ppt
Schiz.pptSchiz.ppt
Schiz.ppt
 
Phsychosomatic disorders
Phsychosomatic disordersPhsychosomatic disorders
Phsychosomatic disorders
 
Bipolar Disorders I & II
Bipolar Disorders I & IIBipolar Disorders I & II
Bipolar Disorders I & II
 
somatic symptom disorder.ppt
somatic symptom disorder.pptsomatic symptom disorder.ppt
somatic symptom disorder.ppt
 
Schizophrenia spectrum & other psychotic disorders.pptx
Schizophrenia spectrum & other psychotic disorders.pptxSchizophrenia spectrum & other psychotic disorders.pptx
Schizophrenia spectrum & other psychotic disorders.pptx
 
Somatoform disorders
Somatoform disorders Somatoform disorders
Somatoform disorders
 
Seminar on approach to schizophrenia.pptx
Seminar on approach to schizophrenia.pptxSeminar on approach to schizophrenia.pptx
Seminar on approach to schizophrenia.pptx
 
OVERVIEW OF SOMATOFORM DISORDERS AND ITS MANAGEMENT.pptx
OVERVIEW OF SOMATOFORM DISORDERS AND ITS MANAGEMENT.pptxOVERVIEW OF SOMATOFORM DISORDERS AND ITS MANAGEMENT.pptx
OVERVIEW OF SOMATOFORM DISORDERS AND ITS MANAGEMENT.pptx
 
adjustment disorders and distress in Palliative care
adjustment disorders and distress in Palliative careadjustment disorders and distress in Palliative care
adjustment disorders and distress in Palliative care
 
basic concepts about schizophrenia spectrum (1).pptx
basic concepts about schizophrenia spectrum (1).pptxbasic concepts about schizophrenia spectrum (1).pptx
basic concepts about schizophrenia spectrum (1).pptx
 
SOMATOFORM AND DISSOCIATIVE DISORDERS
SOMATOFORM AND DISSOCIATIVE DISORDERSSOMATOFORM AND DISSOCIATIVE DISORDERS
SOMATOFORM AND DISSOCIATIVE DISORDERS
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Unit 6 Psychological disorders and therapy.pptx
Unit 6 Psychological disorders and therapy.pptxUnit 6 Psychological disorders and therapy.pptx
Unit 6 Psychological disorders and therapy.pptx
 
Dr chakor
Dr chakorDr chakor
Dr chakor
 
the-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdfthe-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdf
 
the-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdfthe-different-types-of-depression-how-to-spot-them.pdf
the-different-types-of-depression-how-to-spot-them.pdf
 

Recently uploaded

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 

Other Psychotic Disorders

  • 1. Other Psychotic Disorders University of Massachusetts, Amherst Nursing 690 Donna Petko, MSN, RN, APN, FNP-BC March 30, 2015
  • 2. Objective • prevalence • diagnostic criteria • development • functional consequences • cultural issues • measurements • diagnostic features • specifiers • severity levels • differential diagnoses • ICD-10 coding To increase understanding of Other Psychotic Disorders listed in the DSM-5 (APA, 2013):
  • 4. Other Psychotic Disorders Consist of the following (APA, 2013): • Brief Psychotic Disorder • Substance/Medication-Induced Psychotic Disorder • Psychotic Disorder d/t Another Medical Condition
  • 5. Brief Psychotic Disorder Prevalence (APA, 2013): • may account for 9% of cases of first-onset psychosis (US) • more common in developing countries • more common in females than males: 2 to 1
  • 6. Brief Psychotic Disorder cont. Diagnostic Criteria (APA, 2013): • Presence of 1 or more of the following: • Delusions • Hallucinations • Disorganized speech • Grossly disorganized or catatonic behaviors • Duration ≥1 day to < 1 month • Not better explained by: • Major depressive, bipolar disorder with psychotic features • Another psychotic disorder (schizophrenia or catatonia) • Not attributable to substance use, another medical condition
  • 7. Brief Psychotic Disorder cont. Development and course (APA, 2013): • May appear in adolescence/early adulthood • Onset can occur throughout lifespan • Average age of onset mid 30s • Diagnosis requires full remission of all symptoms and eventual return to premorbid level of functioning within 1 month of onset
  • 8. Brief Psychotic Disorder cont. Functional Consequences (APA, 2013): • Despite high rates of relapse, outcome is excellent in social functioning and symptomatology, for most individuals Cultural Issues (APA, 2013): • Cultural and religious backgrounds must be considered • E.g., some individuals report hearing voices in religious ceremonies but these do not persist and are not perceived as abnormal by the individual’s community
  • 9. Brief Psychotic Disorder cont. Measurements: • Clinician-Rated Dimensions of Psychosis Symptom Severity (APA, 2013) • 5-point scale • Covers 8 domains: • delusions, hallucinations, disorganized speech, abnormal psychomotor behavior, negative symptoms, impaired cognition, depression, and mania • Useful in treatment planning, prognostic decision-making, and research on pathophysiological mechanisms • Use at regular intervals; the higher the score, the worse the functioning
  • 10. Brief Psychotic Disorder cont. Diagnostic Features (APA, 2013): • Sudden onset of at least one positive symptom: delusions, hallucinations, disorganized speech, or grossly abnormal psychomotor behavior, including catatonia • ≥ 1 day to < 1 month Specifiers: • with marked stressors • without marked stressors • with postpartum onset • with catatonia
  • 11. Brief Psychotic Disorder cont. Severity Levels (APA, 2013): • Severity is rated by quantitative assessment: • Clinician-Rated Dimensions of Psychosis Symptom Severity Differential Diagnoses (APA, 2013): • Other medical conditions • Substance-related disorders • Depressive/bipolar disorders • Other psychotic disorders • Malingering/factitious disorders • Personality disorders
  • 12. Brief Psychotic Disorder cont. ICD-10 Coding (APA, 2013): • 298.8 (F23)
  • 13. Substance/Medication-Induced Psychotic Disorder Prevalence (APA, 2013): • Unknown in general population • Between 7-25% of individuals presenting with first episode in various settings are reported to have SMIPD
  • 14. Substance/Medication-Induced Psychotic Disorder cont. Diagnostic Criteria (APA, 2013): • Presence of 1 or both of the following: • Delusions • Hallucinations • Evidence from Hx, PE, or labs of both 1 & 2: • Symptoms in criterion A developed during/soon after substance/medication intoxication, exposure or withdrawal • Involved substance/medication capable of producing symptoms in criterion A
  • 15. Substance/Medication-Induced Psychotic Disorder cont. Diagnostic Criteria cont. (APA, 2013): The disturbance: • not better explained by other psychotic disorder that is not substance/medication-induced • does not occur exclusively during the course of a delirium • causes clinically significant distress/impairment in social, occupational, or other areas of functioning
  • 16. Substance/Medication-Induced Psychotic Disorder cont. Development and course (APA, 2013): • Onset may vary based on substance • E.g., smoking a high dose of cocaine may induce psychosis within minutes • Substance/medication-induced psychotic disorder may persist even when offending agent is removed • E.g., amphetamines may induce psychotic states lasting weeks or longer • Polypharmacy may cause psychosis
  • 17. Substance/Medication-Induced Psychotic Disorder cont. Functional Consequences (APA, 2013): • Typically severely disabling and seen more in ER • Disability is typically self-limited and resolves when offending agent is removed Cultural Issues (ISMP, 2003): • Some cultures/races respond differently to medications based on genetic differences • Practices such as fasting may alter medication levels
  • 18. Substance/Medication-Induced Psychotic Disorder cont. Measurements: • Clinician-Rated Dimensions of Psychosis Symptom Severity (APA, 2013) • 5-point scale • 8 domains: • delusions, hallucinations, disorganized speech, abnormal psychomotor behavior, negative symptoms, impaired cognition, depression, and mania • Useful in treatment planning, prognostic decision-making, and research on pathophysiological mechanisms • Use at regular intervals; the higher the score, the worse the functioning
  • 19. Substance/Medication-Induced Psychotic Disorder cont. Diagnostic Features (APA, 2013): • Prominent delusions/hallucinations (Criterion A) • d/t physiological effects of substance/medication • must be evidence in Hx, PE, or labs of both: • symptoms in criterion A developed during or soon after use • involved substance/medication is capable of producing symptoms in criterion A • Not better explained by a psychotic disorder that is not substance/medication-induced • Does not occur exclusively during course of a delirium • Causes clinically significant distress/impairment
  • 20. Substance/Medication-Induced Psychotic Disorder cont. Specifiers (APA, 2013): • with onset during intoxication • with onset during withdrawal Severity Levels (APA, 2013): • Severity is rated by quantitative assessment: • Clinician-Rated Dimensions of Psychosis Symptom Severity Differential Diagnoses (APA, 2013): • Substance intoxication or substance withdrawal • Primary psychotic disorder • Psychotic disorder due to another medical condition
  • 22. Psychotic Disorder d/t Another Medical Condition Prevalence (APA, 2013): • Estimated lifetime prevalence 0.21-0.54% • Ages 65+ have > prevalence 0.74% • More common in untreated endocrine, metabolic, autoimmune disorders; temporal lobe epilepsy • Among older individuals, may be higher in females, but unclear
  • 23. Psychotic Disorder d/t Another Medical Condition cont. Diagnostic Criteria (APA, 2013: • Prominent hallucinations or delusions • Evidence from Hx, PE, or labs indicating direct pathophysiological consequence of another medical condition • The disturbance: • not better explained by another mental disorder • does not occur exclusively during course of delirium • causes clinically significant distress/impairment in social, occupational, or other areas of functioning
  • 24. Psychotic Disorder d/t Another Medical Condition cont. Development and course (APA, 2013): • May be a single transient state or recurrent • Treatment of underlying medical condition usually rectifies, but not always: • E.g., psychotic symptoms may persist after brain injury • Condition may be long term in chronic conditions like MS • Older adults have higher prevalence of the disorder • d/t increasing medical burden, advanced age, cumulative effects of age-related processes • Younger age groups more affected by epilepsy, head trauma, autoimmune, and neoplastic events
  • 25. Psychotic Disorder d/t Another Medical Condition cont. Functional Consequences (APA, 2013): • Typically severe due to another medical condition • Varies considerably by the type of condition • Likely to improve with successful resolution of condition Cultural Issues (ISMP, 2003): • Some cultures/races respond differently to medications based on genetic differences • Practices such as fasting may alter medication levels • Individuals may not take medications to treat medical conditions d/t cultural norms/expectations
  • 26. Psychotic Disorder d/t Another Medical Condition cont. Measurements: • Clinician-Rated Dimensions of Psychosis Symptom Severity (APA, 2013) • 5-point scale • Covers 8 domains: • delusions, hallucinations, disorganized speech, abnormal psychomotor behavior, negative symptoms, impaired cognition, depression, and mania • Useful in treatment planning, prognostic decision-making, and research on pathophysiological mechanisms • Use at regular intervals; the higher the score, the worse the functioning
  • 27. Psychotic Disorder d/t Another Medical Condition cont. Diagnostic Features (APA, 2013): • Prominent delusions/hallucinations • Evidence from Hx, PE, labs that disturbance is result of pathophysiological consequence of another medical condition • Not better explained by another mental disorder • Doe not occur exclusively during course of delirium • Causes clinically significant stress or impairment in social, occupational, or other areas of functioning
  • 28. Psychotic Disorder d/t Another Medical Condition cont. Specifiers (APA, 2013): • Based on predominant symptom: • With delusions • With hallucinations Severity Levels (APA, 2013): • Severity is rated by quantitative assessment: • Clinician-Rated Dimensions of Psychosis Symptom Severity Differential Diagnoses (APA, 2013): • Delirium • Substance/medication-induced psychotic disorder • Psychotic disorder
  • 29. Psychotic Disorder d/t Another Medical Condition cont. ICD-10 (APA, 2013): • Code based on predominant symptom: • 293.81 (F06.2) with delusions • 293.82 (F06.0) with hallucinations • Coding note: • Include the name of the other medical condition in the name of the mental disorder; the other medical condition should be coded and listed separately immediately before the psychotic disorder
  • 31. Case Study A 50-year-old man, nonalcoholic, with uncontrolled diabetes mellitus and hypertension was admitted to the hospital with history of high- grade fever and cough with scanty expectoration, of 2 days’ duration; and burning micturition and ulcer over left foot. Clinically the patient was febrile and diagnosed to have community-acquired left lower lobe pneumonia with urinary tract infection and cellulites of left foot. Investigations revealed Hb was 10.4 g/dl, total leukocyte count was 9,500 cells/mm3 with neutrophilia, E.S.R. was 60 mm at one hour, random blood sugar was 250 mg/dl, blood urea was 25 mg/dl, serum creatinine was 1.3 mg/dl with normal creatinine clearance, and serum electrolytes were within normal limits. Peripheral smear for malarial parasite was negative. Urine microscopy showed 15-18 pus cells/high power field. However, urine culture was sterile and urine ketone bodies were negative. Blood and sputum culture did not grow any organisms (Moorthy, Raghavendra, & Venkatarathnamma, 2008, para. 3).
  • 32. Case Study cont. • Final diagnosis of type 2 diabetes mellitus with hypertension with community-acquired pneumonia and urinary tract infection and cellulites of left foot with ulcer was made. In view of multiple infections, intravenous amoxicillin (1 g) and clavulanic acid (200 mg) every 8th hour were started and continued for 10 days. His general condition improved, and repeat chest x-ray showed resolution of pneumonia with better lung aeration. Cellulitis and urinary tract infection also showed improvement, and blood sugar and hypertension were under control. After 10 days, oral levofloxacin (500 mg/day) was started as a sequential therapy in view of persisting foot ulcer. On the third day of therapy, he became restless and speech became irrelevant and incoherent. Later he became abusive, violent and experienced visual hallucinations of people in his hospital room. Gradually his confusion worsened and he became more violent in nature. He slept very little (Moorthy et al., 2008, para. 3).
  • 33. What do you think is causing the psychosis?
  • 34. Case Study cont. Psychiatric evaluation was suggestive of acute psychosis. The diagnosis of acute psychosis cannot be attributed to the clinical diagnosis as the patient had good improvement following 10 days of intravenous amoxicillin and clavulanic acid therapy. Other conditions like hypoglycemia, dyselectrolytemia, diabetic ketoacidosis, and meningitis were ruled out. Other drugs the patient was receiving were insulin, enalapril, atorvastatin, which are not known to result in such psychosis. So the likely possibility of levofloxacin-induced acute psychosis was considered and levofloxacin was stopped. Within 48 h of stopping levofloxacin, repeat psychiatric evaluation revealed him to be alert and oriented with no further hallucinations. His speech was normal in flow and content, and his concentration and recall were intact. He did not require any antipsychotic medications (Moorthy et al., 2008, para. 3).
  • 35. References American Psychiatric Association. (2013). Clinician-rated dimensions of psychosis symptom severity. Retrieved from http://www.psychiatry.org /File%20Library/ Practice/DSM/DSM-5/ClinicianRatedDimensionsOf PsychosisSymptomSeverity.pdf American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington D.C.: Author. Institute for Safe Medical Practices. (2003). Cultural diversity and medication safety. Retrieved from http://www.ismp.org/ newsletters/acutecare/articles/20030904.asp
  • 36. References cont. Moorthy, M. Raghavendra, N, & Venkatarathnamma, P.N. (2008). Levofloxacin-induced acute psychosis. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745871

Editor's Notes

  1. Hx = history; PE = physical examination
  2. Hx = history; PE = physical exam
  3. MS = multiple sclerosis
  4. Hx = history; PE = physical examination